| Financial Year |
March 31 2023 |
| Monetary Funds |
759,142,509.39 |
| Held-for-trading Financial Assets |
18,660,749.33 |
| Notes Receivable |
17,329,047.61 |
| Accounts Receivable |
646,569,676.78 |
| Advances to Suppliers |
331,670,116.72 |
| Other Receivables |
192,406,852.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
25,062,246.58 |
| Dividend Receivable |
-- |
| Inventories |
404,183,758.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
216,836,150.75 |
| Total Current Assets |
2,588,597,173.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
947,099,471.48 |
| Investment Properties |
-- |
| Fixed Assetes |
1,550,732,168.35 |
| Under-construction Projects |
280,333,698.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
183,705,093.12 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
181,692,694.38 |
| R&D expenses |
4,381,190.24 |
| Goodwill |
20,196,304.81 |
| Long-Term Deferred and Prepaid Expenses |
30,202,065.30 |
| Deferred Income Tax Assets |
46,000,351.75 |
| Other Non-Current Assets |
360,193,327.55 |
| Sub-Total of Non-Current Assets |
3,684,615,664.48 |
| Total Assets |
6,273,212,837.91 |
| Short-Term Loans |
1,234,705,592.28 |
| Trading Financial liabilities |
-- |
| Notes Payable |
117,878,566.47 |
| Accounts Payable |
429,249,290.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,527,943.92 |
| Taxes Payable |
30,707,467.52 |
| Interest Payable |
11,149,634.82 |
| Dividend Payable |
452,812.60 |
| Other payables |
450,971,145.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
928,599,387.40 |
| Other Current Liabilities |
60,444,847.21 |
| Sub-Total of Current Liabilities |
3,371,232,177.62 |
| Long-term Loans |
630,831,314.56 |
| Bonds Payable |
100,000,000.00 |
| Long-Term Accounts Payable |
38,614,368.52 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,266,813.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
951,882,711.81 |
| Total Liabilities |
4,323,114,889.43 |
| Paid-In Capital(Or Share Stock) |
869,099,335.00 |
| Capital Surplus |
1,304,526,894.60 |
| Surplus Reserve |
59,010,460.16 |
| LESS:Treasury Stock |
125,208,014.00 |
| Undistributed Profits |
-433,203,809.08 |
| Minority Stockholder's Interest |
390,870,402.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,559,227,546.09 |
| Owner's Equity（Stockholder's Equity） |
1,950,097,948.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,273,212,837.91 |
